Associate Professor of Medicine
Oncology
Dr. James F. Cleary, MD
|
|
Give Review
James Cleary practices Oncology. He received awards:"CMS Meaningful Use Stage 1 Certification". James F. Cleary is also a published MD. He has 58 paper published. The most recent paper is: Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients.
Publications
- Increasing worldwide access to medical opioids.
- Costs, affordability, and feasibility of an essential package of Cancer control interventions in low-income and middle-income countries: key messages from Disease Cont...
- Optimisation of the continuum of supportive and palliative care for patients with breast Cancer in low-income and middle-income countries: executive summary of the Bre...
- Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness: A Randomized Clinical Trial.
- Are Corticosteroids Effective in All Patients With Cancer-Related Pain?
- Palliative care reduces morbidity and mortality in Cancer.
- Multivariate analysis of countries' government and health-care system influences on opioid availability for Cancer pain relief and palliative care: More than a functio...
- Supportive and palliative care for metastatic breast Cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus...
- CHESS improves Cancer caregivers' burden and mood: Results of an eHealth RCT.
- Opioid Availability and Palliative Care in Nepal: Influence of an International Pain Policy Fellowship.
- Health Literacy and Urbanicity Among Cancer Patients.
- Reply to A. Azad et al.
- Examining Influences on the Availability of and Access to Opioids for Pain Management and Palliative Care.
- An eHealth system supporting palliative care for patients with non-small cell lung Cancer: A randomized trial.
- Inpatient Hospitalization of Oncology Patients: Are We Missing an Opportunity for End-of-Life Care?
- Using a Morphine Equivalence Metric to Quantify Opioid Consumption: Examining the Capacity to Provide Effective Treatment of Debilitating Pain at the Global, Regional,...
- Creating a Bond Between Caregivers Online: Effect on Caregivers' Coping Strategies.
- Ensuring patient access to essential medicines while minimizing harmful use: a revised World Health Organization tool to improve national drug control policy.
- Web-based Cancer communication and decision making systems: connecting patients, caregivers, and clinicians for improved health outcomes.
- Caregivers' participation in the oncology clinic visit mediates the relationship between their information competence and their need fulfillment and clinic visit satis...
- Cancer health disparities persist among African Americans in Wisconsin.
- A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough Cancer pain.
- Cancer information sources used by patients to inform and influence treatment decisions.
- Opioid analgesics for pain control: wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices.
- Comprehensive IMRT plus weekly cisplatin for advanced head and neck Cancer: the University of Wisconsin experience.
- Access to therapeutic opioid medications in Europe by 2011? Fifty years on from the single convention on narcotic drugs.
- Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy.
- Integrating a narrative medicine telephone interview with online life review education for Cancer patients: lessons learned and future directions.
- Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.
- Predictors of hospice utilization among acute stroke patients who died within thirty days.
- Materials to prepare hospice families for dying in the home.
- Development and implementation of a clinician reporting system for advanced stage Cancer: initial lessons learned.
- Caregivers' differing needs across key experiences of the advanced Cancer disease trajectory.
- Patient/Caregiver influences for declining participation in supportive oncology trials.
- Characterizing hospice services in the United States.
- The pharmacologic management of Cancer pain.
- Flecainide for the treatment of Chronic neuropathic pain: a Phase II trial.
- Integrating palliative care into head and neck oncology.
- Effects of prayer and religious expression within computer support groups on women with breast Cancer.
- Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast Cancer.
- Accusations of murder and euthanasia in end-of-life care.
- A day in the life of European palliative care.
- Endocrine effects of tamoxifen plus exemestane in postmenopausal women with breast Cancer.
- Incident pain.
- Respecting each other.
- Consensus statement: Palliative and supportive care in advanced heart failure.
- Treatment of pain crisis at end of life from severe lower extremity venous outflow obstruction with hyperalgesia and allodynia.
- Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol.
- A phase I study of 5-fluorouracil, leucovorin and levamisole.
- Phase I clinical and pharmacokinetic study of Oral carboxyamidotriazole, a signal transduction inhibitor.
- Pharmacokinetic and pharmacodynamic issues in the treatment of breakthrough pain.
- Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in Cancer patients.
- Responding to SUPPORT: an academic medical center examines its end-of-life care practices. Study to Understand Prognoses and Preferences for Outcomes and Risks of Trea...
- Cancer pain management.
- Palliative medicine in the elderly.
- Lung Cancer: review of the ECOG experience. Eastern Cooperative Oncology Group.
- Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in Cancer patients receiving morphine.
Procedures Preformed
- Thoracentesis
Conditions Treated
- Anemia
- Bladder Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- View All
Doctors Specialties
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
The University of Adelaide Faculty of Health Sciences
Hospital
-
University of Wisconsin Hospital and Clinics
Drug Facts
| NPI NUMBER | 1841266855 | |
| NPPES Provider LastName | CLEARY | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 53792 | |
| NPPES Provider State | WI | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 478.0 | |
| Distinct Opioid Count | 9.0 | |
| Opioid Claim Count | 266.0 | |
| Percent Opioid Claims | 55.65 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1841266855 |
| Last Name Of The Provider | CLEARY |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Dr. Shannon E. O'Mahar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Huie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. H I. Robins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glenn Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fotios Asimakopoulos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dustin A. Deming, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sam J. Lubner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy P. Cetnar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Hei, MD
This Doctor is OpenDoctor Recommended.
|